UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042362
Receipt number R000048359
Scientific Title Comparison of Alzheimer disease patients and healthy controls in easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: Verification using normal database of our institution
Date of disclosure of the study information 2020/11/10
Last modified on 2020/11/05 21:02:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of Alzheimer disease patients and healthy controls in easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: Verification using normal database of our institution

Acronym

Comparison of AD and Healthy in eZIS with differential image reconstruction methods using SPECT/CT: Verification using NDB of our institution

Scientific Title

Comparison of Alzheimer disease patients and healthy controls in easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: Verification using normal database of our institution

Scientific Title:Acronym

Comparison of AD and Healthy in eZIS with differential image reconstruction methods using SPECT/CT: Verification using NDB of our institution

Region

Japan


Condition

Condition

Alzheimer disease

Classification by specialty

Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The present study aimed to construct an AD-specific VOI using e-ZIS-assisted 99mTc-ethyl cysteinate dimer (ECD) SPECT/CT images. In addition, we compared the differential diagnostic ability between HC and patients with AD using the FBP and OSEM image reconstruction methods.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

In order to verify the difference between the two types of image reconstruction, we will create a VOI for eZIS analysis from the data of AD patients and healthy controlts acquired at our institution. eZIS analysis is performed on the analysis data, and ROC analysis is used to evaluate which of the image reconstruction FBP and OSEM methods has the higher differential diagnosis ability.

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

AD patients:
Detailed interview with a psychiatrist and patients positive for 11C-PiBPET


Healthy controls:
Those who do not have organic diseases by MRI etc.

Key exclusion criteria

Patients who are unsuitable for physical activity or test data during the test

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Ohba

Organization

Yamagata University Hospital

Division name

Department of Radiology

Zip code

990-9585

Address

2-2-2 Iida-Nishi, Yamagata, 990-9585 Japan

TEL

0236331122

Email

m-ohba@med.id.yamagata-u.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Ohba

Organization

Yamagata University Hospital

Division name

Department of Radiology

Zip code

990-9585

Address

2-2-2 Iida-Nishi, Yamagata, 990-9585 Japan

TEL

0236331122

Homepage URL


Email

m-ohba@med.id.yamagata-u.ac.jp


Sponsor or person

Institute

Yamagata University Hospital

Institute

Department

Personal name



Funding Source

Organization

Yamagata University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethical Review Committee of Yamagata University Faculty of Medicine

Address

2-2-2 Iida-Nishi, Yamagata, 990-9585 Japan

Tel

023-635-5047

Email

ikekenkyu@jm.kj.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

102

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 03 Month 30 Day

Date of IRB

2017 Year 06 Month 30 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2020 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Paper submission schedule


Management information

Registered date

2020 Year 11 Month 05 Day

Last modified on

2020 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048359


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name